Literature DB >> 27582814

The angiotensin-converting enzyme gene insertion-deletion polymorphism in a white British patient cohort with obstetric cholestasis.

Roman Müllenbach1, Natasha Tetlow2, Amanda Bennett3, Fiona Broughton Pipkin4, Linda Morgan5, Catherine Williamson2.   

Abstract

The DD genotype of the angiotensin-converting enzyme (ACE) gene is over-represented in Finnish patients with obstetric cholestasis (OC). The purpose of this study was to establish whether this genotype is associated with cholestasis in UK cases. In a retrospective case-control study, we determined the ACE insertion/deletion frequencies in 166 British cases and 100 control women by polymerase chain reaction analysis. No significant difference in allele frequencies was found between these groups, but allele frequencies differed significantly between Finnish and UK OC cases (P = 0.0005). The prevalence of the DD genotype is lower in UK cases than in controls (χ(2) [1 d.f.] = 4.32, P = 0.05) and the odds ratio for OC associated with the DD genotypeis 0.54, 95% confidence interval 0.30-0.97. In contrast to Finnish OC cases, the DD genotype of the ACE is not increased in UK cases.

Entities:  

Keywords:  angiotensin-converting enzyme; gene polymorphism; obstetric cholestasis

Year:  2009        PMID: 27582814      PMCID: PMC4989727          DOI: 10.1258/om.2009.090005

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  30 in total

1.  ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy.

Authors:  R Müllenbach; K J Linton; S Wiltshire; N Weerasekera; J Chambers; E Elias; C F Higgins; D G Johnston; M I McCarthy; C Williamson
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

2.  Recurrent jaundice of pregnancy; a clinical study of twenty-two cases.

Authors:  A SVANBORG; S OHLSSON
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

3.  Are changes in expression of actin genes involved in estrogen-induced cholestasis?

Authors:  M A Reyes-Romero
Journal:  Med Hypotheses       Date:  1990-05       Impact factor: 1.538

4.  A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction.

Authors:  N J Samani; J R Thompson; L O'Toole; K Channer; K L Woods
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

5.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

6.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

Authors:  M Marre; X Jeunemaitre; Y Gallois; M Rodier; G Chatellier; C Sert; L Dusselier; Z Kahal; L Chaillous; S Halimi; A Muller; H Sackmann; B Bauduceau; F Bled; P Passa; F Alhenc-Gelas
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

7.  Sequence variation in the human angiotensin converting enzyme.

Authors:  M J Rieder; S L Taylor; A G Clark; D A Nickerson
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

8.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

9.  Prevalence of intrahepatic cholestasis of pregnancy in Chile.

Authors:  H Reyes; M C Gonzalez; J Ribalta; H Aburto; C Matus; G Schramm; R Katz; E Medina
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

10.  Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.

Authors:  P G Kehoe; C Russ; S McIlory; H Williams; P Holmans; C Holmes; D Liolitsa; D Vahidassr; J Powell; B McGleenon; M Liddell; R Plomin; K Dynan; N Williams; J Neal; N J Cairns; G Wilcock; P Passmore; S Lovestone; J Williams; M J Owen
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.